Click for best price
Microneedles for Trans & Intradermal Drug Delivery Market Size, Share 2022
Market Analysis and Insights: Global Microneedles for Trans & Intradermal Drug Delivery Market
The global Microneedles for Trans & Intradermal Drug Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microneedles for Trans & Intradermal Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microneedles for Trans & Intradermal Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microneedles for Trans & Intradermal Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microneedles for Trans & Intradermal Drug Delivery market.
Global Microneedles for Trans & Intradermal Drug Delivery Scope and Market Size
Microneedles for Trans & Intradermal Drug Delivery market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Microneedles for Trans & Intradermal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles
Segment by Application
Drugs
Vaccines
Proteins
Peptides
Others
By Company
Becton Dickinson
Nanopass Technologies
Radius Health
Clearside Biomedical
Dr. Prausnitz Group
Zosano Pharma
Corium International
Circassia
Valeritas, Inc.
BD Medical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Microneedles for Trans & Intradermal Drug Delivery product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Microneedles for Trans & Intradermal Drug Delivery, with price, sales, revenue, and global market share of Microneedles for Trans & Intradermal Drug Delivery from 2019 to 2022.
Chapter 3, the Microneedles for Trans & Intradermal Drug Delivery competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microneedles for Trans & Intradermal Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Microneedles for Trans & Intradermal Drug Delivery market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Microneedles for Trans & Intradermal Drug Delivery.
Chapter 13, 14, and 15, to describe Microneedles for Trans & Intradermal Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Microneedles for Trans & Intradermal Drug Delivery Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Microneedles for Trans & Intradermal Drug Delivery Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Microneedles for Trans & Intradermal Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolvable Microneedles
1.3 Market by Application
1.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drugs
1.3.3 Vaccines
1.3.4 Proteins
1.3.5 Peptides
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Estimates and Forecasts 2017-2028
2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Estimates and Forecasts 2017-2028
2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region
2.4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022)
2.4.2 Global Sales Microneedles for Trans & Intradermal Drug Delivery by Region (2023-2028)
2.5 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region
2.5.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022)
2.5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturers
3.1.1 Global Top Microneedles for Trans & Intradermal Drug Delivery Manufacturers by Sales (2017-2022)
3.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Microneedles for Trans & Intradermal Drug Delivery in 2021
3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturers
3.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturers (2017-2022)
3.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2021
3.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type
4.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Sales by Type (2017-2022)
4.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Sales by Type (2023-2028)
4.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
4.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type
4.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Revenue by Type (2017-2022)
4.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Revenue by Type (2023-2028)
4.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
4.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type
4.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2022)
4.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application
5.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Sales by Application (2017-2022)
5.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Sales by Application (2023-2028)
5.1.3 Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application
5.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Historical Revenue by Application (2017-2022)
5.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecasted Revenue by Application (2023-2028)
5.2.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application
5.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2022)
5.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Application (2023-2028)
6 North America
6.1 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
6.1.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
6.1.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
6.2 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
6.2.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
6.2.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
6.3 North America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
6.3.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
6.3.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
7.1.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
7.1.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
7.2 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
7.2.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
7.2.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
7.3 Europe Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
7.3.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
7.3.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
8.1.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
8.1.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
8.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
8.2.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
8.2.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
8.3 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market Size by Region
8.3.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2028)
8.3.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
9.1.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
9.1.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
9.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
9.2.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
9.2.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
9.3 Latin America Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
9.3.1 Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
9.3.2 Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Type
10.1.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2028)
10.1.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2028)
10.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Application
10.2.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2028)
10.2.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2028)
10.3 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market Size by Country
10.3.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2028)
10.3.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Corporation Information
11.1.2 Becton Dickinson Overview
11.1.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Becton Dickinson Recent Developments
11.2 Nanopass Technologies
11.2.1 Nanopass Technologies Corporation Information
11.2.2 Nanopass Technologies Overview
11.2.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nanopass Technologies Recent Developments
11.3 Radius Health
11.3.1 Radius Health Corporation Information
11.3.2 Radius Health Overview
11.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Radius Health Recent Developments
11.4 Clearside Biomedical
11.4.1 Clearside Biomedical Corporation Information
11.4.2 Clearside Biomedical Overview
11.4.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Clearside Biomedical Recent Developments
11.5 Dr. Prausnitz Group
11.5.1 Dr. Prausnitz Group Corporation Information
11.5.2 Dr. Prausnitz Group Overview
11.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr. Prausnitz Group Recent Developments
11.6 Zosano Pharma
11.6.1 Zosano Pharma Corporation Information
11.6.2 Zosano Pharma Overview
11.6.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zosano Pharma Recent Developments
11.7 Corium International
11.7.1 Corium International Corporation Information
11.7.2 Corium International Overview
11.7.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Corium International Recent Developments
11.8 Circassia
11.8.1 Circassia Corporation Information
11.8.2 Circassia Overview
11.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Circassia Recent Developments
11.9 Valeritas, Inc.
11.9.1 Valeritas, Inc. Corporation Information
11.9.2 Valeritas, Inc. Overview
11.9.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Valeritas, Inc. Recent Developments
11.10 BD Medical
11.10.1 BD Medical Corporation Information
11.10.2 BD Medical Overview
11.10.3 BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BD Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Microneedles for Trans & Intradermal Drug Delivery Industry Chain Analysis
12.2 Microneedles for Trans & Intradermal Drug Delivery Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Microneedles for Trans & Intradermal Drug Delivery Production Mode & Process
12.4 Microneedles for Trans & Intradermal Drug Delivery Sales and Marketing
12.4.1 Microneedles for Trans & Intradermal Drug Delivery Sales Channels
12.4.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
12.5 Microneedles for Trans & Intradermal Drug Delivery Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Microneedles for Trans & Intradermal Drug Delivery Industry Trends
13.2 Microneedles for Trans & Intradermal Drug Delivery Market Drivers
13.3 Microneedles for Trans & Intradermal Drug Delivery Market Challenges
13.4 Microneedles for Trans & Intradermal Drug Delivery Market Restraints
14 Key Findings in The Global Microneedles for Trans & Intradermal Drug Delivery Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Solid Microneedles
Table 3. Major Manufacturers of Hollow Microneedles
Table 4. Major Manufacturers of Dissolvable Microneedles
Table 5. Global Microneedles for Trans & Intradermal Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 8. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2022)
Table 9. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 10. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2023-2028)
Table 11. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2017-2022)
Table 13. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region (2023-2028)
Table 15. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Manufacturers (2017-2022)
Table 17. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Manufacturers (2017-2022)
Table 19. Microneedles for Trans & Intradermal Drug Delivery Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Microneedles for Trans & Intradermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Microneedles for Trans & Intradermal Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedles for Trans & Intradermal Drug Delivery as of 2021)
Table 22. Microneedles for Trans & Intradermal Drug Delivery Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Microneedles for Trans & Intradermal Drug Delivery Product Offered
Table 24. Date of Manufacturers Enter into Microneedles for Trans & Intradermal Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 27. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 28. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Type (2017-2022)
Table 29. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Type (2023-2028)
Table 30. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Type (2017-2022)
Table 33. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Type (2023-2028)
Table 34. Microneedles for Trans & Intradermal Drug Delivery Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 37. Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 38. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Application (2017-2022)
Table 39. Global Microneedles for Trans & Intradermal Drug Delivery Sales Share by Application (2023-2028)
Table 40. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Application (2017-2022)
Table 43. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Application (2023-2028)
Table 44. Microneedles for Trans & Intradermal Drug Delivery Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 47. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 48. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 51. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 52. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 55. North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 56. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 59. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 60. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 63. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 64. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 67. Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 68. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country (2023-2028) & (US$ Million)
Table 106. Becton Dickinson Corporation Information
Table 107. Becton Dickinson Description and Major Businesses
Table 108. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Becton Dickinson Recent Developments
Table 111. Nanopass Technologies Corporation Information
Table 112. Nanopass Technologies Description and Major Businesses
Table 113. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Nanopass Technologies Recent Developments
Table 116. Radius Health Corporation Information
Table 117. Radius Health Description and Major Businesses
Table 118. Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Radius Health Recent Developments
Table 121. Clearside Biomedical Corporation Information
Table 122. Clearside Biomedical Description and Major Businesses
Table 123. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Clearside Biomedical Recent Developments
Table 126. Dr. Prausnitz Group Corporation Information
Table 127. Dr. Prausnitz Group Description and Major Businesses
Table 128. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Dr. Prausnitz Group Recent Developments
Table 131. Zosano Pharma Corporation Information
Table 132. Zosano Pharma Description and Major Businesses
Table 133. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Zosano Pharma Recent Developments
Table 136. Corium International Corporation Information
Table 137. Corium International Description and Major Businesses
Table 138. Corium International Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Corium International Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Corium International Recent Developments
Table 141. Circassia Corporation Information
Table 142. Circassia Description and Major Businesses
Table 143. Circassia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Circassia Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Circassia Recent Developments
Table 146. Valeritas, Inc. Corporation Information
Table 147. Valeritas, Inc. Description and Major Businesses
Table 148. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Valeritas, Inc. Recent Developments
Table 151. BD Medical Corporation Information
Table 152. BD Medical Description and Major Businesses
Table 153. BD Medical Microneedles for Trans & Intradermal Drug Delivery Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. BD Medical Microneedles for Trans & Intradermal Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. BD Medical Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Microneedles for Trans & Intradermal Drug Delivery Distributors List
Table 159. Microneedles for Trans & Intradermal Drug Delivery Customers List
Table 160. Microneedles for Trans & Intradermal Drug Delivery Market Trends
Table 161. Microneedles for Trans & Intradermal Drug Delivery Market Drivers
Table 162. Microneedles for Trans & Intradermal Drug Delivery Market Challenges
Table 163. Microneedles for Trans & Intradermal Drug Delivery Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Microneedles for Trans & Intradermal Drug Delivery Product Picture
Figure 3. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Type in 2021 & 2028
Figure 3. Solid Microneedles Product Picture
Figure 4. Hollow Microneedles Product Picture
Figure 5. Dissolvable Microneedles Product Picture
Figure 6. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Application in 2021 & 2028
Figure 7. Drugs
Figure 8. Vaccines
Figure 9. Proteins
Figure 10. Peptides
Figure 11. Others
Figure 12. Microneedles for Trans & Intradermal Drug Delivery Report Years Considered
Figure 13. Global Microneedles for Trans & Intradermal Drug Delivery Sales 2017-2028 (K Units)
Figure 14. Global Microneedles for Trans & Intradermal Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Microneedles for Trans & Intradermal Drug Delivery Revenue 2017-2028 (US$ Million)
Figure 16. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2017-2022)
Figure 18. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region (2023-2028)
Figure 19. North America Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 20. North America Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Microneedles for Trans & Intradermal Drug Delivery Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Microneedles for Trans & Intradermal Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Microneedles for Trans & Intradermal Drug Delivery in the World: Market Share by Microneedles for Trans & Intradermal Drug Delivery Revenue in 2021
Figure 31. Global Microneedles for Trans & Intradermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 33. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 34. Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 35. Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 36. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 37. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 38. North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 39. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 40. North America Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
Figure 41. North America Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
Figure 42. U.S. Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 45. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 46. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 47. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 48. Europe Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
Figure 49. Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
Figure 50. Germany Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 51. France Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Region (2017-2028)
Figure 61. China Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 64. India Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 72. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 74. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
Figure 76. Latin America Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
Figure 77. Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Share by Country (2017-2028)
Figure 86. Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Microneedles for Trans & Intradermal Drug Delivery Revenue (2017-2028) & (US$ Million)
Figure 89. Microneedles for Trans & Intradermal Drug Delivery Value Chain
Figure 90. Microneedles for Trans & Intradermal Drug Delivery Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
